Jason J. Luke

The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients

Vyara Matson, Jessica Fessler, Riyue Bao et al. · Science · 2018 · 2.8K citations

Safety and Efficacy of Durvalumab (MEDI4736), an Anti–Programmed Cell Death Ligand-1 Immune Checkpoint Inhibitor, in Patients With Advanced Urothelial Bladder Cancer

Christophe Massard, Michael S. Gordon, Sunil Sharma et al. · Journal of Clinical Oncology · 2016 · 839 citations · Full text

Noninvasive Detection of Response and Resistance in <i>EGFR</i> -Mutant Lung Cancer Using Quantitative Next-Generation Genotyping of Cell-Free Plasma DNA

Geoffrey R. Oxnard, Cloud P. Paweletz, Yanan Kuang et al. · Clinical Cancer Research · 2014 · 772 citations

WNT/β-catenin Pathway Activation Correlates with Immune Exclusion across Human Cancers

Jason J. Luke, Riyue Bao, Randy F. Sweis et al. · Clinical Cancer Research · 2019 · 642 citations · Full text

Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study

Jeffrey S. Weber, Matteo S. Carlino, Adnan Khattak et al. · The Lancet · 2024 · 598 citations

Medicine, Melanoma, Immunology +7